Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Medecine Sciences : M/S|March 20, 2026
[Assessing the risk-benefit balance of medicines: Some lessons from Covid-19]Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 26, 2015
Effect of continuous vs pulsed iontophoresis of treprostinil on skin blood flowSylvain Kotzki, Matthieu Roustit, Claire Arnaud, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 25, 2025
Trial-level Surrogacy of non-High-Density and Low-Density Lipoprotein Cholesterol Reduction on the Clinical Efficacy of StatinsLéa Liaigre, Alicia Guigui, Marc Manceau, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 21, 2017
Hierarchical evaluation of electrical stimulation protocols for chronic wound healing: An effect size meta-analysisCharles Khouri, Sylvain Kotzki, Matthieu Roustit, et al.
British Journal of Clinical Pharmacology|April 17, 2016
Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysisCharles Khouri, Thomas Jouve, Sophie Blaise, et al.
Microvascular Research|May 23, 2017
Reproducibility of flow mediated skin fluorescence to assess microvascular functionMarcin Hellmann, Maria Tarnawska, Maria Dudziak, et al.
Therapie|June 14, 2014
[Pharmacology of Raynaud's phenomenon]Matthieu Roustit, Charles Khouri, Sophie Blaise, et al.
The Journal of Rheumatology|July 4, 2008
Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosisMatthieu Roustit, Grant H Simmons, Jean-Philippe Baguet, et al.
British Journal of Clinical Pharmacology|March 8, 2016
Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockersCharles Khouri, Sophie Blaise, Patrick Carpentier, et al.
Chest|December 25, 2017
Comparative Safety of Drugs Targeting the Nitric Oxide Pathway in Pulmonary Hypertension: A Mixed Approach Combining a Meta-Analysis of Clinical Trials and a Disproportionality Analysis From the World Health Organization Pharmacovigilance DatabaseCharles Khouri, Marion Lepelley, Matthieu Roustit, et al.
Pageof 23